BioCatalyst

AP203, AP203 — catalyst calendar

1 verified catalyst event(s) referencing AP203, AP203, each linked to its official source. Verified as of 2026-11-04.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 27d
ESTIMATED
 READOUT
A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP
Phase 1/2 · Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC)
 AP Biosciences Inc. AP203, AP203 ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.